Get the Stockscreener App
21.28
1.53%
0.32
After Hours:
21.30
0.02
+0.09%
Tectonic Therapeutic Inc stock is traded at $21.28, with a volume of 151.01K.
It is up +1.53% in the last 24 hours and down -25.36% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$20.96
Open:
$21.08
24h Volume:
151.01K
Relative Volume:
0.70
Market Cap:
$416.01M
Revenue:
Net Income/Loss:
$-83.49M
P/E Ratio:
-4.7745
EPS:
-4.457
Net Cash Flow:
$-60.29M
1W Performance:
-6.46%
1M Performance:
-25.36%
6M Performance:
-28.33%
1Y Performance:
+22.72%
1-Day Range:
$21.05
$21.51
1-Week Range:
$20.60
$23.61
52-Week Range:
$15.45
$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.28 | 416.01M | 0 | -83.49M | -60.29M | -4.457 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-12-26 | Initiated | UBS | Neutral |
| May-26-26 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-14-26 | Initiated | Stifel | Buy |
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Sep-03-25 | Initiated | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
After 525 shares were withheld for taxes, Tectonic Therapeutic (TECX)'s medical chief holds 67,157 shares. - Stock Titan
An officer holds 44,903 shares after Tectonic Therapeutic (TECX) withholds 411 for taxes. - Stock Titan
After 520 shares were withheld for taxes, Tectonic Therapeutic (TECX) CFO holds 58,024 shares. - Stock Titan
493 shares are proposed for sale by officer Peter McNamara at Tectonic Therapeutic (TECX). - Stock Titan
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare - Yahoo Finance
Tectonic Therapeutic CFO Lochner Daniel Receives 24,250 Derivative Securities Award - Kalkine Media
Tectonic Therapeutic (TECX) ties CFO option grant to 42-month vesting schedule - Stock Titan
Tectonic Therapeutic (TECX) grants CEO 69,250 stock options with extended vesting - Stock Titan
Tectonic Therapeutic (TECX) awards CBO 17,750 stock options - Stock Titan
Tectonic Therapeutic (TECX) grants 24,250 options to its CMO - Stock Titan
Stock-option grant gives Tectonic Therapeutic (TECX) CSO 21,000 rights to buy shares - Stock Titan
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewswire
Tectonic Therapeutic advances TX45 trial with s... - pluang.com
Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case - Seeking Alpha
Tectonic Therapeutic Loses US$152m Market Value But Insiders See Windfall Of US$72k - simplywall.st
Tectonic (NASDAQ: TECX) ex-director lines up another stock sale - Stock Titan
Mizuho Securities Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $85 - Moomoo
Tectonic Therapeutic (NASDAQ: TECX) ex-director to sell 10,200 shares - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.6% HigherShould You Buy? - MarketBeat
TECX Q2 2026 Earnings: Narrower-than-Expected Loss Lifts Shares 2.74%Earnings Surprise Report - vinanet.vn
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com UK
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - MarketBeat
Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo
Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
TECX Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Wells Fargo & Company Issues Pessimistic Forecast for Tectonic Therapeutic (NASDAQ:TECX) Stock Price - MarketBeat
Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring A 159.58% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
TECX Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Pipeline Remains the FocusEarnings Revision Report - vinanet.vn
Tectonic Therapeutic, Inc. Stock 12‑Month Price Target Cut to $77.56, Implies 157% Upside - TradingView
Tectonic Therapeutic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tectonic Therapeutic, Inc. 2Q 2026: Net loss $22.3M, EPS $(1.18) — 10-Q Summary - TradingView
TECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingView
Press Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire
TECX,RNAC Options - Finviz
Tectonic Therapeutic Inc expected to post a loss of $1.35 a shareEarnings Preview - TradingView
Tectonic Therapeutic (TECX) Holds Ground at $27.95 as Traders Eye $26.55 SupportTurnaround Stocks - vinanet.vn
Tectonic Therapeutic Inc Stock (TECX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PETER MCNAMARA | Officer |
Sep 30 '26 |
Proposed Sale |
23.34 |
493 |
11,507 |
0 |
| TERRANCE MCGUIRE | Former Director |
Aug 27 '26 |
Proposed Sale |
36.83 |
7,513 |
276,718 |
0 |
| McNamara Peter | Chief Scientific Officer |
Aug 25 '26 |
Option Exercise |
14.71 |
43 |
633 |
55,328 |
| McNamara Peter | Chief Scientific Officer |
Aug 25 '26 |
Sale |
36.52 |
43 |
1,570 |
55,285 |
| TERRANCE MCGUIRE | Former Director |
Aug 21 '26 |
Proposed Sale |
37.61 |
10,200 |
383,671 |
0 |
| PETER MCNAMARA | Officer |
Aug 12 '26 |
Proposed Sale |
31.87 |
129 |
4,111 |
0 |
| McNamara Peter | Chief Scientific Officer |
Aug 12 '26 |
Sale |
35.00 |
43 |
1,505 |
55,285 |
| McNamara Peter | Chief Scientific Officer |
Aug 12 '26 |
Option Exercise |
14.71 |
43 |
633 |
55,328 |
| PETER MCNAMARA | Officer |
Jun 30 '26 |
Proposed Sale |
33.09 |
172 |
5,691 |
0 |
| McNamara Peter | Chief Scientific Officer |
Jun 30 '26 |
Option Exercise |
14.71 |
172 |
2,530 |
55,457 |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):